Kastalia Medrano 
CDC and ONDCP Issue Health Alert for Medetomidine, an Unusual Move
On April 6 the White House announced a Health Alert Network (HAN) advisory warning ...
Congress Poised to Schedule Xylazine, Because Otherwise the DEA Will Do It
Three years in the making, the legislative push to place xylazine under Schedule III ...
Illinois Overdose Prevention Center Bill Is Moving Forward Again
In Illinois, a bill to authorize an overdose prevention center (OPC) pilot is working ...
Rezenopy, the 10 Mg Naloxone Nasal Spray, Enters the OD Antidote Market
Two years after its approval by the Food and Drug Administration, opioid-overdose reversal product ...
DEA Emergency Order Puts Novel Benzo Bromazolam in Schedule I
The Drug Enforcement Administration has temporarily placed bromazolam, an unregulated benzodiazepine, under Schedule I ...
Mortality Rate for LA’s Unhoused Residents Drops for the First Time
For the first time in the decade that the Los Angeles County Department of ...
FDA Eyeing “Drug Disposal” Products, for Destroying Rx Opioids at Home
The Food and Drug Administration is asking the public to weigh in on the ...
CDC Identifies Specific Drugs Most Frequently Cited in Overdose Deaths
On March 5, the Centers for Disease Control and Prevention a published a National Vital ...
No, Synthetic Opioid Cychlorphine Has Not Proved Narcan “Ineffective”
A minor media frenzy has been forming around cychlorphine, a novel synthetic opioid described ...
DEA Permanently Bans Five Benzos, the First to Be Placed in Schedule I
On March 2, the Drug Enforcement Administration published a final rule permanently scheduling five ...
